Reviva Pharmaceuticals Holdings Financial Overview
Reviva Pharmaceuticals Holdings's market cap is currently $31.99M. The company's EPS TTM is $-0.06; its P/E ratio is -0.61; Reviva Pharmaceuticals Holdings is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
